BIOMAT Database Logo BIOMAT Database Logo

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. 1998

T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Istituto per la Chimica di Molecole di Interesse Biologico, C.N.R., Napoli, Italy.

Fatty acid amide hydrolase (FAAH) catalyzes the hydrolysis of bioactive fatty acid amides and esters such as the endogenous cannabinoid receptor ligands, anandamide (N-arachidonoyl-ethanolamine) and 2-arachidonoylglycerol, and the putative sleep inducing factor cis-9-octadecenoamide (oleamide). Most FAAH blockers developed to date also inhibit cytosolic phospholipase A2 (cPLA2) and/or bind to the CB1 cannabinoid receptor subtype. Here we report the finding of four novel FAAH inhibitors, two of which, malhamensilipin A and grenadadiene, were screened out of a series of thirty-two different algal natural products, and two others, arachidonoylethylene glycol (AEG) and arachidonoyl-serotonin (AA-5-HT) were selected out of five artificially functionalized polyunsaturated fatty acids. When using FAAH preparations from mouse neuroblastoma N18TG2 cells and [14C]anandamide as a substrate, the IC50s for these compounds ranged from 12.0 to 26 microM, the most active compound being AA-5-HT. This substance was also active on FAAH from rat basophilic leukaemia (RBL-2H3) cells (IC50 = 5.6 microM), and inhibited [14C]anandamide hydrolysis by both N18TG2 and RBL-2H3 intact cells without affecting [14C]anandamide uptake. While AEG behaved as a competitive inhibitor and was hydrolyzed to arachidonic acid (AA) by FAAH preparations, AA-5-HT was resistant to FAAH-catalyzed hydrolysis and behaved as a tight-binding, albeit non-covalent, mixed inhibitor. AA-5-HT did not interfere with cPLA2-mediated, ionomycin or antigen-induced release of [3H]AA from RBL-2H3 cells, nor with cPLA2 activity in cell-free experiments. Finally, AA-5-HT did not activate CB1 cannabinoid receptors since it acted as a very weak ligand in in vitro binding assays, and, at 10-15 mg/kg body weight, it was not active in the 'open field', 'hot plate' and rectal hypothermia tests carried out in mice. Conversely AEG behaved as a cannabimimetic substance in these tests as well as in the 'ring' immobility test where AA-5-HT was also active. AA-5-HT is the first FAAH inhibitor reported to date which is inactive both against cPLA2 and at CB1 receptors, whereas AEG represents a new type of cannabinoid receptor agonist.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D005026 Ethylene Glycols An ethylene compound with two hydroxy groups (-OH) located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze. Dihydroxyethanes,Ethanediols,Glycols, Ethylene
D000581 Amidohydrolases Any member of the class of enzymes that catalyze the cleavage of amide bonds and result in the addition of water to the resulting molecules. Amidases,Amidohydrolase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001095 Arachidonic Acids Eicosatetraenoic Acids,Acids, Arachidonic,Acids, Eicosatetraenoic

Related Publications

T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Novel inhibitors of fatty acid amide hydrolase.
June 2007, Bioorganic & medicinal chemistry letters,
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Novel propanamides as fatty acid amide hydrolase inhibitors.
August 2017, European journal of medicinal chemistry,
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).
March 2008, Bioorganic & medicinal chemistry letters,
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Fatty acid amide hydrolase inhibitors--progress and potential.
August 2011, CNS & neurological disorders drug targets,
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents.
May 2021, ACS chemical neuroscience,
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Sulfonyl fluoride inhibitors of fatty acid amide hydrolase.
November 2012, Journal of medicinal chemistry,
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity.
November 2007, Biochemistry,
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
March 2010, Journal of medicinal chemistry,
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Fatty acid amide hydrolase inhibitors and the marijuana debate.
November 2001, Lancet (London, England),
T Bisogno, and D Melck, and L De Petrocellis, and Bobrov MYu, and N M Gretskaya, and V V Bezuglov, and N Sitachitta, and W H Gerwick, and V Di Marzo
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase.
September 2008, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!